CEO Sets Sights On Building Shareholder Value At Theratechnologies Inc.; Getting Lead Drug To Market Top Priority
MONTREAL--(BUSINESS WIRE)--Dec. 15, 2005--Theratechnologies (TSX:TH) today announced strategic initiatives aimed at maximizing shareholder value. The strategy and related business plan were developed over the past few months and approved by the Board of Directors yesterday.